Cephalosporin resistant bacterial strains isolated from respiratory infections

1. Du B, I. (2003). Restriction of third-generation cephalosporin use decreases infection-related mortality. Crit Care Med. 31, 1088-109310.1097/01.CCM.0000059315.07526.DA12682477Search in Google Scholar

2. Hedrick, J.A. (2010). Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins. Expert Rev Anti Infect Ther. 8(1), 15-21. DOI: 10.1586/ eri.09.11510.1586/eri.09.11520014898Search in Google Scholar

3. Endimiani, A., Perez, F. & Bonomo, R. (2008). Cefepime: reappraisal in an era of increasing antimicrobial resistance. Expert Rev Anti Infect Ther. 6, 805-82410.1586/14787210.6.6.805263365719053894Search in Google Scholar

4. Niculescu, C. & Iordache, E. (2007). Recomandarea Academiei Americane de Pediatrie pentru prescrierea cefalosporinelor la pacienţii alergici la penicilină. Craiova Medicală. 9(4)Search in Google Scholar

5. Buiuc, D. & Neguţ, M. (1999). Tratat de Microbiologie Clinică. Bucureşti: Ed. MedicalăSearch in Google Scholar

6. CLSI 2012 M100, S13 ( M2-A11), EUCAST Breakpoint Table v. 2.0, valid from 2012-01-01Search in Google Scholar

7. Chaudhary, M., Shrivastava, S.M., Varughese, L. & Sehgal, R. (2008). Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. Curr Clin Pharmacol. 3, 118-12210.2174/15748840878429366018700304Search in Google Scholar

8. Palladino, J.A., Sunderlin, J.L., Singer, M.E., Adelman, M.H. & Schentag, J.J. (2008). Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance. Am J Health Syst Pharm. 65, 1154-115910.2146/ajhp07043518541686Search in Google Scholar

9. Tumah, H.N. (2004). In vitro activity of cefepime and cefpirome compared to other thirdgeneration cephem antibiotics against gramnegative nosocomial pathogens. Pharmazie. 59, 854-858Search in Google Scholar